Variant report
Variant | esv14526 |
---|---|
Chromosome Location | chr11:104005959-104006418 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188366091 | chr11:104005960-104005961 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs11226193 | chr11:104005970-104005971 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs531295013 | chr11:104005976-104005977 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547982103 | chr11:104006033-104006034 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568144898 | chr11:104006047-104006048 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11226194 | chr11:104006051-104006052 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs11226195 | chr11:104006061-104006062 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs567042487 | chr11:104006103-104006104 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs578191565 | chr11:104006117-104006118 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs11226196 | chr11:104006135-104006136 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs151299104 | chr11:104006158-104006159 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2515075 | chr11:104006183-104006184 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs192250439 | chr11:104006184-104006185 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113409121 | chr11:104006186-104006187 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543083253 | chr11:104006191-104006192 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11226197 | chr11:104006219-104006220 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs574574376 | chr11:104006257-104006258 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11226198 | chr11:104006261-104006262 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs11226199 | chr11:104006300-104006301 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs73603983 | chr11:104006326-104006327 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs361273 | chr11:104006346-104006347 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs144259248 | chr11:104006368-104006369 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531254990 | chr11:104006371-104006372 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs147777791 | chr11:104006395-104006396 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11226200 | chr11:104006409-104006410 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs61892486 | chr11:104006414-104006415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Melanoma | 17363583 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Obesity | 19966786 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:103997000-104013400 | Weak transcription | Ovary | ovary |
2 | chr11:104004400-104006400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr11:104004600-104006200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
4 | chr11:104005000-104006000 | Enhancers | HUVEC | blood vessel |
5 | chr11:104005200-104006000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr11:104005200-104006200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr11:104005200-104006200 | Enhancers | HMEC | breast |
8 | chr11:104005400-104007000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
9 | chr11:104005800-104006400 | Enhancers | A549 | lung |
10 | chr11:104005800-104007400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr11:104005800-104007400 | Weak transcription | Fetal Heart | heart |
12 | chr11:104005800-104019400 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
13 | chr11:104005800-104031000 | Weak transcription | Aorta | Aorta |
14 | chr11:104006000-104007000 | Weak transcription | HUVEC | blood vessel |
15 | chr11:104006200-104013400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr11:104006400-104006800 | Weak transcription | A549 | lung |
17 | chr11:104006400-104007200 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |